相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2020)
Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients-A Controlled Clinical Trial
Philipp Simon et al.
ANTIBIOTICS-BASEL (2020)
Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis
Lisa Ehmann et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models
Sofie A. M. Dhaese et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?
Anouk E. Muller et al.
DRUGS (2018)
Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model
Iris K. Minichmayr et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Principles of fluid management and stewardship in septic shock: it is time to consider the four D's and the four phases of fluid therapy
Manu L. N. G. Malbrain et al.
ANNALS OF INTENSIVE CARE (2018)
Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis
Jonathan A. Silversides et al.
INTENSIVE CARE MEDICINE (2017)
The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections
Massimo Sartelli et al.
WORLD JOURNAL OF EMERGENCY SURGERY (2017)
Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study
Lisa Ehmann et al.
CRITICAL CARE (2017)
Population Pharmacokinetics of Meropenem During Continuous Infusion in Surgical ICU Patients
Martin G. Kees et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The impact of fluid balance on diagnosis, staging and prediction of mortality in critically ill patients with acute kidney injury
Charat Thongprayoon et al.
JOURNAL OF NEPHROLOGY (2016)
A rational approach to fluid therapy in sepsis
P. Marik et al.
BRITISH JOURNAL OF ANAESTHESIA (2016)
Fluid overload in the ICU: evaluation and management
Rolando Claure-Del Granado et al.
BMC Nephrology (2016)
TDMx: A novel web-based open-access support tool for optimising antimicrobial dosing regimens in clinical routine
Sebastian G. Wicha et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Comparison of the Accuracy and Precision of Pharmacokinetic Equations To Predict Free Meropenem Concentrations in Critically Ill Patients
Gloria Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The effect of pathophysiology on pharmacokinetics in the critically ill patient - Concepts appraised by the example of antimicrobial agents
Stijn I. Blot et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Urinary organic anion transporter protein profiles in AKI
Margarita Kunin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study
Suvi T. Vaara et al.
CRITICAL CARE (2012)
Simultaneous determination of eight β-lactam antibiotics in human serum by liquid chromatography-tandem mass spectrometry
Tomofumi Ohmori et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams
Joao Goncalves-Pereira et al.
CRITICAL CARE (2011)
Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
Andrew A. Udy et al.
CLINICAL PHARMACOKINETICS (2010)
Pharmacokinetic and pharmacodynamic properties of meropenem
David P. Nicolau
CLINICAL INFECTIOUS DISEASES (2008)
Characterization of CS-023 (RO4908463), a novel parenteral carbapenem antiobiotic, and meropenem as substrates of human renal transporter
Takahiro Shibayam et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients
Chonghua Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem
HA Mattoes et al.
CLINICAL THERAPEUTICS (2004)
分享论文
